<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01516424</url>
  </required_header>
  <id_info>
    <org_study_id>D4906011</org_study_id>
    <nct_id>NCT01516424</nct_id>
  </id_info>
  <brief_title>Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone</brief_title>
  <official_title>A Randomized, Double-blinded, Double-dummy, Parallel-controlled and Multicenter Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sumitomo Pharmaceutical (Suzhou) Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sumitomo Pharmaceutical (Suzhou) Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Randomized, Double-blinded, Double-dummy, Parallel-controlled and Multicenter Clinical
      trial to Investigate Blonanserin in Treatment of Schizophrenia when compared with Risperidone
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Randomized, Double-blinded, Double-dummy, Parallel-controlled and Multicenter Clinical
      trial to Investigate Blonanserin in Treatment of Schizophrenia when compared with Risperidone

      Trial drugs:

        -  Blonanserin group: Blonanserin tablets+Risperidone mimetic tablets

        -  Risperidone group: Risperidone tablets+Blonanserin mimetic tablets

      Objectives of Study :

      To evaluate the efficacy and safety of Blonanserin in treating schizophrenia
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean change in PANSS total score</measure>
    <time_frame>week 8</time_frame>
    <description>Mean change in PANSS total score from baseline at Week 8</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean change in CGI-S score</measure>
    <time_frame>week 8</time_frame>
    <description>Mean change in CGI-S score from baseline at Week 8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in PANSS negative, positive and general scale</measure>
    <time_frame>Week 8</time_frame>
    <description>Mean change in PANSS negative, positive and general scale from baseline at Week 8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in PANSS 5-factor model</measure>
    <time_frame>Week 8</time_frame>
    <description>Mean change in PANSS 5-factor model from baseline at Week 8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in PANSS symptom scores</measure>
    <time_frame>Week 8</time_frame>
    <description>Mean change in PANSS symptom scores from baseline at Week 8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in PANSS symptom scores from baseline at each Visit</measure>
    <time_frame>Each Visit</time_frame>
    <description>Mean change in PANSS symptom scores from baseline at each Visit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">267</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Risperidone, Schizophrenia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Blonanserin, Schizophrenia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Blonanserin</intervention_name>
    <description>tablet,4mg,b.i.d</description>
    <arm_group_label>Blonanserin, Schizophrenia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Risperidone</intervention_name>
    <description>tablet,2mg,b.i.d,</description>
    <arm_group_label>Risperidone, Schizophrenia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject met DSM-IV-TR criteria for a primary diagnosis of schizophrenia

          -  Patients are 18≤age≤65 years of age on the day when informed consent is obtained.

          -  Subject had a PANSS total score ≥70 and 120≥ at Screening

          -  Subject had a score ≥4 on the PANSS at Screening and Baseline.

          -  Subjects are willing and able to comply with study protocol including treatment in
             hospital.

          -  Subjects or their legal guardians have signed the written informed consent form.

        Exclusion Criteria:

          -  The subject was treatment with other Investigate product within 30 days.

          -  Subject had a history of treatment with long-acting drug for anti schizophrenia within
             56 days.

          -  Subject had a history of treatment with clozapine within 28 days.

          -  Subject With parkinson disease,etc
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niufan Gu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Mental Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beijing Anding Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100088</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Huilongguan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100096</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peking University Sixth Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guangzhou Brain Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510170</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hebei Province Mental Health Center</name>
      <address>
        <city>Baoding</city>
        <state>Hebei</state>
        <zip>071000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Harbin Medical University</name>
      <address>
        <city>Harbin</city>
        <state>Heilongjiang</state>
        <zip>150001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henan Provincial Mental Hospital</name>
      <address>
        <city>Xinxiang</city>
        <state>Henan</state>
        <zip>453002</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hunan Province Brain Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nanjing Brain Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wuxi Mental Health Center</name>
      <address>
        <city>Wuxi</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Mental Health Center</name>
      <address>
        <city>Shang Hai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Xi'an Mental Health Center</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710061</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West China Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tianjin Anding Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300222</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Kunming Medical University</name>
      <address>
        <city>Kun Ming</city>
        <state>Yunnan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2012</study_first_submitted>
  <study_first_submitted_qc>January 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2012</study_first_posted>
  <last_update_submitted>December 2, 2013</last_update_submitted>
  <last_update_submitted_qc>December 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blonanserin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Risperidone</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 12, 2015</submitted>
    <returned>February 27, 2015</returned>
    <submitted>May 25, 2017</submitted>
    <returned>December 29, 2017</returned>
    <submitted>May 10, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

